Division of Vascular Surgery, 12297New York University Langone Medical Center, New York, NY, USA.
Department of Surgery, 12297New York University Langone Medical Center, New York, NY, USA.
Vascular. 2023 Feb;31(1):3-9. doi: 10.1177/17085381211052802. Epub 2021 Dec 3.
Contemporary commercially available endovascular devices for the treatment of abdominal aortic aneurysm (AAA) include standard endovascular aortic repair (sEVAR) or fenestrated EVAR (fEVAR) endografts. However, aortic neck dilatation (AND) can occur in nearly 25% of patients following EVAR, resulting in loss of proximal seal with risk of aortic rupture. AND has not been well characterized in fEVAR, and direct comparisons studying AND between fEVAR and sEVAR have not been performed. This study aims to analyze AND in the infrarenal and suprarenal aortic segments, including seal zone, and quantify sac regression following fEVAR implantation compared to sEVAR.
A retrospective review of prospectively collected data on 20 consecutive fEVAR patients (Cook Zenith® Fenestrated) and 20 sEVAR (Cook Zenith®) patients was performed. Demographic data, anatomic characteristics, procedural details, and clinical outcome were analyzed. Pre-operative, post-operative (1 month), and longest follow-up CT scan at an average of 29.3 months for fEVAR and 29.8 months for sEVAR were analyzed using a dedicated 3D workstation (iNtuition, TeraRecon Inc, Foster City, California). Abdominal aortic aneurysm neck diameter was measured in 5 mm increments, ranging from 20 mm above to 20 mm below the lowest renal artery. Sub-analysis comparing the fEVAR to the sEVAR group at 12 months and at greater than 30 months was performed. Standard statistical analysis was done.
Demographic characteristics did not differ significantly between the two cohorts. The fEVAR group had a larger mean aortic diameter at the lowest renal artery, shorter infrarenal aortic neck length, increased prevalence of nonparallel neck shape, and longer AAA length. On follow-up imaging, the suprarenal aortic segment dilated significantly more at all locations in the fEVAR cohort, whereas the infrarenal aortic neck segment dilated significantly less compared to the sEVAR group. Compared to the sEVAR cohort, the fEVAR patients demonstrated significantly greater positive sac remodeling as evident by more sac diameter regression, and elongation of distance measured from the celiac axis to the most cephalad margin of the sac. Device migration, endoleak occurrence, re-intervention rate, and mortalities were similar in both groups.
Compared to sEVAR, patients undergoing fEVAR had greater extent of suprarenal AND, consistent with a more diseased native proximal aorta. However, the infrarenal neck, which is shorter and also more diseased in fEVAR patients, appears more stable in the post-operative period as compared to sEVAR. Moreover, the fEVAR cohort had significantly greater sac shrinkage and improved aortic remodeling. The suprarenal seal zone in fEVAR may result in a previously undescribed increased level of protection against infrarenal neck dilatation. We hypothesize that the resultant decreased endotension conferred by better seal zone may be responsible for a more dramatic sac shrinkage in fEVAR.
目前用于治疗腹主动脉瘤(AAA)的商用血管内设备包括标准血管内主动脉修复术(sEVAR)或开窗血管内修复术(fEVAR)内移植物。然而,EVAR 后近 25%的患者会发生主动脉颈扩张(AND),导致近端密封丢失,增加主动脉破裂风险。fEVAR 中尚未很好地描述 AND,也未进行 fEVAR 和 sEVAR 之间关于 AND 的直接比较研究。本研究旨在分析 fEVAR 植入后肾下和肾上主动脉段的 AND,包括密封区,并定量比较 fEVAR 与 sEVAR 术后的瘤腔缩小。
回顾性分析 20 例连续接受 fEVAR(Cook Zenith® Fenestrated)治疗的患者和 20 例 sEVAR(Cook Zenith®)患者的前瞻性收集数据。分析人口统计学数据、解剖特征、手术细节和临床结果。使用专用的 3D 工作站(iNtuition,TeraRecon Inc,加利福尼亚州福斯特城)分析术前、术后 1 个月和最长随访 29.3 个月(fEVAR)和 29.8 个月(sEVAR)的 CT 扫描。在距离肾动脉最低处上下 20mm 的范围内,以 5mm 的增量测量腹主动脉瘤颈部直径。对 fEVAR 组和 sEVAR 组在 12 个月和 30 个月以上进行亚组分析。进行了标准的统计学分析。
两组的人口统计学特征无显著差异。fEVAR 组在肾动脉最低处的平均主动脉直径较大,肾下主动脉颈长度较短,非平行颈型的发生率较高,AAA 长度较长。在随访影像学检查中,fEVAR 组的肾上段主动脉在所有部位均显著扩张,而肾下段主动脉颈扩张明显小于 sEVAR 组。与 sEVAR 组相比,fEVAR 患者的瘤腔明显缩小,表现为瘤腔直径缩小更多,从腹腔干到瘤腔最颅侧边缘的距离也明显延长。两组的器械迁移、内漏发生、再介入率和死亡率相似。
与 sEVAR 相比,接受 fEVAR 的患者发生肾上 AND 的程度更大,这与更严重的原发性近端主动脉病变一致。然而,fEVAR 患者的肾下段较短,病变程度也更严重,与 sEVAR 相比,术后更稳定。此外,fEVAR 组的瘤腔明显缩小,主动脉重塑得到改善。fEVAR 的肾上密封区可能导致以前未描述的对肾下段扩张的更高水平的保护。我们假设,更好的密封区带来的减少的内张力可能是 fEVAR 中瘤腔更明显缩小的原因。